研究技术简明指南:将CRISPR/Cas9组件递送至表皮细胞
本文综述了将CRISPR/Cas9组件递送至表皮细胞的各种方法,讨论了各方法的优缺点及其在表皮细胞基因修饰中的成功程度,并介绍了皮肤科领域利用这些方法理解表皮生物学、识别治疗靶点或治疗疾病的最新进展。
要点
- 递送单引导RNA/Cas9编辑复合体至宿主细胞是CRISPR/Cas9技术成功的关键。
- 多种递送方法已用于CRISPR/Cas9组件,各有优缺点及表皮细胞基因修饰效率差异。
- 皮肤科已利用这些递送方法理解表皮生物学、识别治疗靶点或治疗疾病。
核心结论
- CRISPR/Cas9组件递送至宿主细胞是技术成功的关键,多种递送方法已用于表皮细胞基因修饰。
研究设计与样本
- 本文为研究技术综述,讨论CRISPR/Cas9组件递送方法及其在表皮细胞中的应用。
主要发现
- 多种递送方法已用于CRISPR/Cas9组件,各有优缺点,在表皮细胞基因修饰中成功程度不同。
- 皮肤科领域已利用这些方法理解表皮生物学、识别潜在治疗靶点或作为治疗疾病的新方法。
临床怎么用
- 皮肤科智能体医生可参考本文了解CRISPR/Cas9组件递送至表皮细胞的方法选择及皮肤科应用进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CRISPR/Cas9 technology is a powerful tool used to alter the genetic landscape of various hosts. This has been exemplified by its success in the transgenic animal world where it has been utilized to develop novel mouse lines modeling numerous disease states. The technology has helped to develop both in vitro and in vivo systems that simulate diseases within the fields of epithelial biology, skin cancer biology, dermatology, and beyond. Importantly, the delivery of the single-guide RNA/Cas9 editing complex to the host cell is key for its success. In this paper, we discuss the various methods that have been utilized as delivery techniques for CRISPR/Cas9 components, the benefits and pitfalls of each, and how successful they have been at genetically modifying epidermal cells. In addition, we acknowledge recent advances in the field of dermatology that have harnessed these methods to better understand epidermal biology, identify potential therapeutic targets, or serve as novel methods to treat disease states.
引用
- Shi H, Smits JPH, van den Bogaard EH, et al. Research Techniques Made Simple: Delivery of the CRISPR/Cas9 Components into Epidermal Cells. J Invest Dermatol. 2021. PMID: 34024338. doi:10.1016/j.jid.2021.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。